Strip pack
AssigneeDrugtech Corporation
InventorsMarc S. Hermelin, Mitchell I. Kirschner, Sjoerd Osinga
Life of this patent
Estimating the term…
Abstract
The present invention relates to a disposable dispensing apparatus which provides optimal therapeutic support to humans and other animals by conveniently supplying a complex dosing regimen requiring simultaneous administration of storage-incompatible or unevenly dosed components in a shelf stable user-friendly format. The present invention is particularly useful for humans with special therapeutic needs, such as pregnant, lactating and/or menopausal women.
Claims44
A disposable dispensing apparatus for providing optimal therapeutic support to an animal by increasing compliance with a complex dosing regimen and facilitating simultaneous administration of storage-incompatible substances, said apparatus comprising:
- a blister pack having a plurality of predetermined areas, each of said predetermined areas defining at least a first recess and a second recess, the first and second recesses each defining a separate area for storing incompatible substances, the incompatible substances being selected from the group consisting of hydrophobic compounds and hydrophilic compounds, olefinic compounds and non-olefinic compounds, pH sensitive compounds and non-pH sensitive compounds, substances requiring an anhydrous environment and substances requiring a non-anhydrous environment, acidic drugs and basic drugs, effervescent tablets and high water content drugs or dosage forms, gelatin capsules and aldehydes, guarternary ammonium compounds and anionic substances, and combinations thereof, respectively;
- a first dosage unit occupying the first recess, said first dosage unit comprising a first biologically-active substance;
- a second dosage unit occupying the second recess, said second dosage unit comprising a second biologically-active substance;
- wherein the complex dosing regimen requires simultaneous administration of said first and second biologically-active substances;
- said first biologically-active substance being storage incompatible with said second biologically-active substance;
- and
- wherein said first recess and said second recess provide shelf stability by independently isolating in close proximity said first dosage unit and said second dosage unit to prevent interaction between the first and second biologically-active substances while facilitating simultaneous administrations of said substances.
A storage stable, disposable dispensing apparatus for increasing patient compliance with taking at least one prescription substance through proximity and conjoint accessibility with at least one nonprescription substance, said apparatus comprising:
- a blister pack having at least one row of a plurality of predetermined areas, each area defining at least two recesses, each of the recesses defining a separate area for storing incompatible substances, the incompatible substances being selected from the group consisting of hydrophobic compounds and hydrophilic compounds, olefinic compounds and non-olefinic compounds, pH sensitive compounds and non-pH sensitive compounds, substances requiring an anhydrous environment, and substances requiring a non-anhydrous environment, acidic and basic drugs, effervescent tablets and high water content drugs or dosage forms, gelatin capsules and aldehydes, quarternary ammonium compounds and anionic substances, and combinations thereof, respectively;
- a first dosage unit occupying at least one recess of at least one of said predetermined areas, said first dosage unit containing a prescription substance selected from the group consisting of a hormone replacement agent, a contraceptive agent, an osteoporotic agent, a chemotherapeutic agent, an anti-infective agent, an analgesic agent, a steroid, an appetite suppressant, a weight loss agent, a tobacco antagonist, a cholesterol reducer and combinations thereof;
- a second dosage unit occupying at least one recess of at least one of said predetermined areas, said second dosage unit containing a prescription therapeutic substance, said second dosage unit arrayed with said first dosage unit on said blister pack adjacent to said second dosage unit;
- a day indicia provided on said blister pack, said day indicia corresponding to at least one of said predetermined areas;
- wherein each of said predetermined areas has a seal that is independently accessible, removable or breakable;
- and
- wherein said disposable dispensing container apparatus is stored in a storage container, wherein said container is divided into a plurality of discrete compartments and wherein at least one compartment is for receiving and storing said blister pack and at least one compartment is for receiving and storing a loose or unpackaged dosage form.
A disposable dispensing apparatus for providing optimal therapeutic support to an animal by increasing compliance with a complex dosing regimen and facilitating administration of uneven doses of a biologically-active substance, said apparatus comprising:
- a blister pack having at least two rows of a plurality of predetermined areas;
- a first row of predetermined areas, each of the predetermined areas defining a first recess adapted to receive a first dosage unit, said first row of predetermined areas having a first time indicia;
- a second row of predetermined areas, each of the predetermined areas defining a first recess adapted to receive a second dosage unit, said second row of predetermined areas having a second time indicia;
- and
- wherein the first dosage unit has a greater or lesser amount by weight of the biologically active than the second dosage unit.
A method for providing optimal therapeutic support to an animal by increasing compliance with a complex dosing regimen and facilitating simultaneous administration of storage-incompatible substances, which comprises:
- providing a blister pack having a plurality of predetermined areas, each of said predetermined areas defining at least a first recess and a second recess;
- providing a first dosage unit occupying the first recess, said first dosage unit comprising a first biologically-active substance;
- providing a second dosage unit occupying the second recess, said second dosage unit comprising a second biologically-active substance;
- providing day indicia on said blister pack, said day indicia corresponding to each of said predetermined areas to increase patient compliance with said complex dosing regimen by indicating which day the dosage units are to be administered;
- administering a nonprescription therapeutic substance and a prescription therapeutic substance together from said blister pack to an animal when indicated by said day indicia;
- wherein the complex dosing regimen requires simultaneous administration of said first and second biologically-active substances;
- said first biologically-active substance being storage-incompatible with said second biologically-active substance;
- and
- wherein said first recess and said second recess provide shelf stability by independently isolating in close proximity said first dosage unit and said second dosage unit to prevent interaction between the first and second biologically-active substances while facilitating simultaneous administration of said substances.
A method for providing optimal therapeutic support to an animal by increasing compliance with a complex dosing regimen and facilitating administration of uneven doses of at least one biologically-active substance, which comprises:
- providing the biologically-active substance in a blister pack having a first row of a plurality of predetermined areas and a second row of a plurality of predetermined areas;
- each predetermined area of the first row defining a recess for receiving a first dosage unit and each predetermined area of the second row receiving a second dosage unit;
- wherein the first row of predetermined areas corresponds to a first time indicia and the second row of predetermined areas corresponds to a second time indicia;
- a second row of predetermined areas, each of the predetermined areas defining a first recess adapted to receive a second dosage unit, said second row of predetermined areas having a second time indicia;
- and
- wherein the first dosage unit and the second dosage unit contain uneven amounts of the biologically-active substance.
Dependencies are inferred from the claim text.